Cargando…
Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the National Kidney Foundation, Inc. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463099/ https://www.ncbi.nlm.nih.gov/pubmed/34571066 http://dx.doi.org/10.1053/j.ajkd.2021.09.002 |
| _version_ | 1784572333681278976 |
|---|---|
| author | Nacasch, Naomi Erez, Daniel Lishner, Michael Benchetrit, Sydney Rozenberg, Ilan Sarel, Erez Shitrit, Pnina Wand, Ori Cohen-Hagai, Keren |
| author_facet | Nacasch, Naomi Erez, Daniel Lishner, Michael Benchetrit, Sydney Rozenberg, Ilan Sarel, Erez Shitrit, Pnina Wand, Ori Cohen-Hagai, Keren |
| author_sort | Nacasch, Naomi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8463099 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | by the National Kidney Foundation, Inc. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84630992021-09-27 Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients Nacasch, Naomi Erez, Daniel Lishner, Michael Benchetrit, Sydney Rozenberg, Ilan Sarel, Erez Shitrit, Pnina Wand, Ori Cohen-Hagai, Keren Am J Kidney Dis Correspondence by the National Kidney Foundation, Inc. Published by Elsevier Inc. 2022-01 2021-09-25 /pmc/articles/PMC8463099/ /pubmed/34571066 http://dx.doi.org/10.1053/j.ajkd.2021.09.002 Text en © 2021 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Nacasch, Naomi Erez, Daniel Lishner, Michael Benchetrit, Sydney Rozenberg, Ilan Sarel, Erez Shitrit, Pnina Wand, Ori Cohen-Hagai, Keren Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients |
| title | Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients |
| title_full | Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients |
| title_fullStr | Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients |
| title_full_unstemmed | Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients |
| title_short | Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients |
| title_sort | long-term antibody response to the bnt162b2 vaccine among maintenance hemodialysis patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463099/ https://www.ncbi.nlm.nih.gov/pubmed/34571066 http://dx.doi.org/10.1053/j.ajkd.2021.09.002 |
| work_keys_str_mv | AT nacaschnaomi longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT erezdaniel longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT lishnermichael longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT benchetritsydney longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT rozenbergilan longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT sarelerez longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT shitritpnina longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT wandori longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients AT cohenhagaikeren longtermantibodyresponsetothebnt162b2vaccineamongmaintenancehemodialysispatients |